Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    17309916 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Enrolling by invitation RenalGuard System and Contrast Media
Condition: Chronic Kidney Disease
Interventions: Device: RenalGuard system;   Drug: Sodium Bicarbonate and N-acetylcysteine
2 Unknown  Sodium Bicarbonate and N-Acetylcysteine for Nephroprotection in Acute Myocardial Infarction
Conditions: Acute Myocardial Infarction;   Acute Kidney Injury
Interventions: Drug: Sodium bicarbonate plus NAC;   Drug: Saline hydration plus NAC
3 Enrolling by invitation Efficacy Trial of N-Acetylcysteine and Sodium Bicarbonate for the Prevention of Contrast-Induced Acute Kidney Injury
Condition: Chronic Kidney Disease
Intervention: Drug: Physiological Saline, N-Acetylcysteine and Sodium Bicarbonate

Indicates status has not been verified in more than two years